|Home | About | Journals | Submit | Contact Us | Français|
Living systems may have evolved probabilistic bet hedging strategies that generate cell-to-cell phenotypic diversity in anticipation of environmental catastrophes, as opposed to adaptation via a deterministic response to environmental changes. Evolution of bet hedging assumes that genotypes segregating in natural populations modulate the level of intraclonal diversity, which so far has largely remained hypothetical. Using a fluorescent Pmet17-GFP reporter, we mapped four genetic loci conferring to a wild yeast strain an elevated cell-to-cell variability in the expression of MET17, a gene regulated by the methionine pathway. A frameshift mutation in the Erc1p transmembrane transporter, probably resulting from a release of laboratory strains from negative selection, reduced Pmet17-GFP expression variability. At a second locus, cis-regulatory polymorphisms increased mean expression of the Mup1p methionine permease, causing increased expression variability in trans. These results demonstrate that an expression quantitative trait locus (eQTL) can simultaneously have a deterministic effect in cis and a probabilistic effect in trans. Our observations indicate that the evolution of transmembrane transporter genes can tune intraclonal variation and may therefore be implicated in both reactive and anticipatory strategies of adaptation.
The genetics of adaptation to environmental conditions are usually apprehended from a deterministic point of view: rare or modified alleles get fixed in a population because they improve the fitness of individuals carrying them. Countless examples illustrate this general Darwinian mechanism of living systems. When environmental conditions fluctuate or change unpredictably, this strategy assumes a reactive mechanism: adapted individuals are those that perceive and respond rapidly to the new conditions. A number of observations support the existence of an alternative and complementary strategy that is probabilistic and based on anticipation. In this case, genotypes may be selected if they confer phenotypic diversity among isogenic individuals carrying them, because some of these carriers may be adapted ‘in advance', ‘by chance'. This strategy is often referred to as bet hedging, because it meets the original definition of a gain of geometric mean fitness over generations, at the cost of decreasing the arithmetic mean fitness (Lewontin and Cohen, 1969; Simons, 2011). Diversifying phenotypes may indeed hedge the bets: it has an immediate cost but can be rewarding in case of a catastrophe. The potential advantage of phenotypic diversification in fluctuating environments has been discussed and was shown to surpass the reactive strategy under certain timings of fluctuations (Kussell and Leibler, 2005; Acar et al, 2008; Stomp et al, 2008). The theory that evolution can act by bet hedging is attractive for two reasons. First, numerous cases of phenotypic diversification have been described that can confer persister individuals after environmental stress. This ranges from the persistence of bacteria after ampicillin treatment (Balaban et al, 2004), of rare yeast cells after severe heat stress (Levy et al, 2012), to the elevated variance in germination time of isogenic plant seeds (Simons and Johnston, 2006) and to the asymmetric distribution of carbon stocks among daughter cells of starved S. meliloti (Ratcliff and Denison, 2010). In addition, individual cells are not equally responsive to stress (Ni et al, 2012) or transcriptional induction (Robert et al, 2010), and this heterogeneity can greatly diversify the population response to environmental changes. Second, various types of mutations may change intraclonal phenotypic diversity. For a discrete adaptive trait, a mutation may change the rate of phenotypic switching between adapted and nonadapted states, for example, by changing the efficiency of a positive feedback loop in a gene regulatory network. For a quantitative adaptive trait, mutations may act on various statistical properties of the trait values among carrier individuals, such as variance or skewness. This may happen by affecting feedback controls, by changing cooperativity at promoters (Becskei et al, 2005) or via the modulation of chromatin dynamics (Raser and O'Shea, 2004), transcriptional elongation (Ansel et al, 2008) or translation efficiency (Guido et al, 2007).
Most genetic studies of phenotypic switching and biological noise have relied on artificial manipulations made in the laboratory. One remarkable example was the experimental evolution of dimorphism in bacteria: extreme selection directly applied on phenotypic switching could fix mutations causing it (Beaumont et al, 2009). But what about natural alleles that segregate in natural populations and through which evolution takes place? Do they confer different levels of phenotypic diversity? If they do, then selection for bet hedging may happen in the wild. Otherwise, such a selective mechanism would first require a step where genotypes generating higher biological noise or modifying phenotypic switches appear in the population. A handful of examples illustrate that natural DNA polymorphisms can confer different levels of phenotypic heterogeneity. An important one is the fact that elevated developmental asymmetry (stochastic differences between left and right body parts) can be fixed using supervised crosses between natural fly stocks (Carter and Houle, 2011). This observation echoed previous reports on natural fly genotypes affecting the sensitivity to environmental variation in bristle number (Mackay and Lyman, 2005). Similar observations were made on snails (Ros et al, 2004) and maize (Ordas et al, 2008) where environmental trait variance was not uniformly seen across genotypes. A concordant example is the different degree of cell–cell variability in cellular morphology among wild yeast strains (Yvert et al, 2013). In humans, two genotypes have been linked to interindividual variation. The Nf1 heterozygous mutation, which causes neurofibromatosis type 1 with varying levels of penetrance, was shown to increase morphological variability among cultured melanocytes from the same donor (Kemkemer et al, 2002). More recently, the FTO gene was not only associated with obesity, but also with interindividual variation of body mass index (Yang et al, 2012). More exhaustively, a genomic study of interindividual variation in plant metabolic and transcriptomic variation identified numerous genetic loci modulating this variability. Remarkably, the authors were able to validate the effect of natural ELF3 alleles on the variation of the period of circadian transcriptional oscillations (Jimenez-Gomez et al, 2011). These examples illustrate that, indeed, natural alleles can confer different degrees of phenotypic noise and may therefore be the subject of selection under appropriate environmental fluctuations.
The existence of these genetic effects suggests that adopting a nondeterministic point of view may sometimes help understand the genetics of complex traits. To refine the usual concept of a quantitative trait locus (QTL) that affects the mean trait value of individuals, we propose to define a probabilistic trait locus (PTL) as a locus that changes the probability that an individual expresses a given trait value in a given genomic and environmental context (Box 1). Under this definition, all QTLs are PTLs but the reverse is not true: a PTL allele may increase the chances to observe individuals with extreme phenotypes (e.g., with either low or high trait values) without necessarily changing the mean trait value of all carriers. A PTL may also change the transition rate between two phenotypic states without modifying the overall proportion of individuals being in one state at a given time. Note that many QTLs have deterministic effects that manifest only in specific genetic or environmental contexts, and therefore only in some individuals. In this case, the locus does not need to be called a PTL because its effect is not inherently probabilistic. Finally, the probabilistic effect of a PTL may be modulated by nonadditive interactions with the genetic background or the environment, just as the deterministic effect of a QTL. Identifying PTL in outbred populations presents two major difficulties. First, if individuals differ at many loci and all have their environmental history, one can hardly distinguish whether the variable expressivity of the phenotype is due to hidden genetic or environmental factors or to a probabilistic effect of the locus. In this regard, model organisms such as recombinant inbred lines of animals or plants are useful: they can be grown in replicates under controlled environmental conditions. The second limitation is the detection power of PTL. At similar power, detecting differences in variance or other high-order moments of a statistical distribution requires larger samples than detecting differences in mean.
A quantitative trait locus (QTL) increases the trait value in individuals carrying a specific genotype at the locus. In contrast, a probabilistic trait locus (PTL) can change the probability that an individual displays a given trait value without necessarily changing the mean trait value of all individuals carrying the genotype. In the example shown, individuals with a B allele at the PTL are more likely to display extreme trait values than individuals with the A allele.
One of the most convenient frameworks for recording very large samples and therefore estimating intraclonal phenotypic distribution accurately is the yeast S. cerevisiae. When the physiological state of cells is reported by fluorescence, flow cytometry offers high-throughput acquisitions on large populations of isogenic individuals. In particular, the response to environmental changes can be estimated. Yeast cells are very sensitive to variations in available sources of sulfur, which can be organic (methionine, cystein) or inorganic. Genetic screens based on methionine auxotrophy have decrypted the regulatory network underlying the metabolism of sulfur assimilation (Thomas and Surdin-Kerjan, 1997). Many genes, such as MET17 that codes for a homocysteine synthase, are repressed in the presence of methionine. A key component of this response is the Met4p transcriptional activator (complexed with Cbf1p and Met28p) that promotes gene activation but only at low intracellular concentrations of S-adenosyl methionine (AdoMet) when it is not degraded by the action of the SCF(Met30) ubiquitin ligase complex (Rouillon et al, 2000). Another important regulator is the Met31p/Met32p transcriptional regulator that prevents the transcription of MET17 while promoting expression of other responsive genes (such as MET3 and MET14) at high intracellular levels of AdoMet (Blaiseau et al, 1997).
Using a fluorescent reporter of MET17 expression (Pmet17-GFP), we previously showed that cell–cell variation in expression could be treated as a complex genetic trait (Ansel et al, 2008). This provides an ideal model system to identify expression PTLs (ePTLs) affecting the statistical properties of the activation of a regulatory pathway. Although this initial study demonstrated the segregation of cell–cell variability across natural genotypes, several limitations prevented a fully informative description (Ansel et al, 2008). First, the fact that cell–cell variability in expression was highly correlated with mean expression values led to identify loci that proved to be eQTLs, and not strictly ePTLs, except for one locus. Second, this strict ePTL locus was caused by a ura3Δ0 mutation that was artificially created in the laboratory for auxotrophic selection purposes. It was therefore informative on the mechanisms generating cell–cell variation but not on the nature of ePTLs segregating in the wild. Finally, this locus explained only a fraction of the difference in cell–cell variation between two genetic backgrounds, leaving all additional putative ePTLs unidentified. We present here the genetic mapping of four of these additional ePTLs, the characterization of their specificity and the identification of natural sequence polymorphisms underlying two of them. This allows us to draw conclusions on the properties of natural alleles modulating intraclonal phenotypic diversification in the wild.
The term ‘cell–cell variability' is used here to define cell-to-cell differences in the level of expression of a gene between isogenic cells grown in a common environment. When single-cell expression levels are recorded by flow cytometry, cell–cell variability can be quantified by the coefficient of variation (CV=s.d. divided by mean) of expression among the population of cells. Note that low expression levels are known to correlate with high CV values, which is consistent with the elevated stochasticity seen in systems harboring low numbers of regulatory molecules.
We previously showed that cell–cell variability in the expression of Pmet17-GFP differed between wild yeast backgrounds (Ansel et al, 2008). It was particularly different between two unrelated S. cerevisiae strains frequently used as a model for complex trait dissection (Ehrenreich et al, 2009). Strain BY, isogenic to S288c, is used as a reference in many laboratories (Brachmann et al, 1998) and strain RM derives from a vineyard isolate (Brem et al, 2002). In our initial study, we showed that cell–cell variability in Pmet17-GFP expression segregated as a quantitative trait in the BY × RM cross. The ura3Δ0 mutation, which had been artificially introduced in RM shortly after its isolation, accounted for ~37% of the increased variability observed in RM (Ansel et al, 2008). Elevated variability of Pmet17-GFP expression remained among RM cells after ‘curing' the URA3 gene (Figure 1A). Thus, the natural genetic loci accounting for the interstrain difference remained to be identified.
Here we describe the mapping of these loci by introgression. We chose this method because it allows uncoupling CV from mean expression. In the BY × RM cross, treating CV values directly as the trait of interest previously led us to identify two loci changing mean expression (eQTLs). These loci also increased cell–cell variability of expression but simply as a consequence of a lower mean expression (Ansel et al, 2008). We reasoned that if the elevated CV values of RM could be introgressed in BY without affecting mean expression, then the genetic sources of cell–cell variability per se could be identified. We therefore performed successive backcrosses, selecting Ura+ segregants of high cell–cell variability and unaffected mean at every generation. Three independent lineages of seven generations produced strains W7, X7 and Z7 that were Ura+ and retained only ~1% of the RM genome (Figure 1B). To analyze the properties of Pmet17-GFP expression in these strains, we cultured them in parallel with a BY control, first in a repressive condition (1mM methionine) and then over a range of decreasing methionine concentrations (200 to 0μM) representing moderate to full activation of the MET17 promoter. All three strains displayed elevated cell–cell variability as compared with BY. Both X7 and Z7 displayed similar mean expression as BY, whereas strain W7 showed a reduced mean expression (Figure 1C). To determine if the increased cell–cell variability of W7 was simply a by-product of its lower mean expression, we fitted a linear model of CV versus mean dependence on the BY values and examined whether W7 samples deviated from this model. This was clearly the case, with CV values significantly higher than expected from the model (Figure 1C). The same was true for X7 and Z7 as well. Thus, at a given mean expression level, all three strains displayed higher cell–cell variability than BY.
If elevated cell–cell variability of W7, X7 and Z7 is because of genotypes inherited from the RM genome, then all loci of RM genotype in these strains are potential ePTL candidates. We therefore sequenced the genome of these strains to determine which parts originated from RM. Paired-end sequencing of genomic DNA from RM, W7, X7 and Z7 was obtained on an Illumina Genome Analyzer IIx, producing ~45 × coverage of each strain. Reads were aligned on the S288c genome. Using the RM data set, we derived 42794 SNPs that we then used to detect RM genotypes in the introgressed strains. A total of 11 regions of RM origin were found in the three strains W7, X7 and Z7, with at least two regions introgressed in each one of them (Figure 1D and Table I). Two regions were single SNPs, likely representing sequencing errors or mutations in our BY strain as compared with the reference S288c genome. They were not considered further. All nine remaining regions were of RM genotype in only one of the three strains. At first sight, this was surprising. The introgression design being the same in all lineages, we expected to find common RM loci conferring high cell–cell variability in all of them. However, given our previous observation of polygenicity, this could simply be due to random drift and bottlenecks. At every generation, we chose one spore out of only ~40. If, for example, six loci account for the elevated variability of RM, then only one spore out of 26=64 would harbor all genetic determinants. In this case, at any of the seven selection steps, measuring expression CV in only 40 spores may have led us to focus on a spore that retained only a subset of the loci of interest. And this subset may differ from one lineage to another.
We therefore considered all remaining nine regions as ePTL candidates and tested them directly on additional data sets. We crossed the seventh generation introgressed strains once more with BY, and performed linkage analysis on the resulting segregants. For example, crossing Z7 with BY generated a set of random spores that were genotyped at loci VI-263987, VIII-160869 and XV-625582, and these spores were analyzed by flow cytometry. To specifically test for an effect on CV and not mean expression, we first conditioned CV on mean expression level before using it as a trait for linkage (see Materials and methods). The rejection of one candidate locus and the validation of another one are shown as examples in Figure 2A and B. As indicated in Table I, four of the nine loci were validated as ePTLs and each introgression lineage contributed at least one validated ePTL.
Strains W7, X7 and Z7 each contained several introgressed loci. To precisely estimate the individual effect of each ePTL, we built strains that were isogenic to BY except for a single locus of interest, and we measured Pmet17-GFP cell–cell variability in these strains at various methionine concentrations (Figure 2C–F). We quantified the gain of cell–cell variability in the presence of each locus by computing the difference between observed CV and its expected value from a linear model fitted on BY samples (Figure 2H, see Materials and methods). The statistical significance of this gain was then tested by a one-tail Student's t-test of departure from zero. The ePTL1 locus showed a CV increase that was statistically significant (P=0.00012) but very mild (0.003 only). In contrast, expression CV increased markedly in response to ePTL7, ePTL8 or ePTL13 with gains of 0.014, 0.018 and 0.019, respectively, in the corresponding strains (Figure 2H). In comparison, the BY/RM difference in CV after removing the effect of the artificial ura3 mutation was 0.031 (Figure 2H). Hence, each of these three loci increased cell–cell variability to an extent of approximately half of the parental difference.
To see how much cell–cell variability could be gained when cumulating all three loci with strong effect, we constructed a strain isogenic to BY except at these loci, which were of RM genotypes. We also brought a fourth locus on chromosome XV (Table I) from RM in this strain because we suspected it to be an additional ePTL, which later proved not to be the case. This strain displayed higher cell–cell variability than any of the strains harboring a single ePTL locus from RM. It also showed a decreased mean expression as compared with both BY and RM (Figure 2G), which was consistent with the small decrease in mean expression seen in each of the three strains harboring a single ePTL from RM. The strain cumulating all three ePTLs showed a CV gain of 0.049, which is comparable to the sum of individual gains conferred by each locus (0.051). Interestingly, when introduced together into BY, the three ePTLs conferred higher cell–cell variability than the level seen in RM (Figure 2G). We previously suspected that BY contributes alleles conferring elevated variability because of the transgressive segregation of CV values in the BY–RM cross (Ansel et al, 2008). Now that the effect of ePTL in the BY context is shown to surpass the variability seen in RM, we can propose that these BY alleles are compensated by one or more of the three ePTLs identified. The fact that the elevated cell–cell variability of RM was recapitulated, and even surpassed, by combining three ePTLs suggests that we successfully mapped the major sources of it from RM.
Genetic variants affecting cell–cell variability in the expression of a reporter gene may do so specifically or not. Specificity is expected if an ePTL changes the transcriptional control at the Pmet17 promoter but not at other promoters, or if it modulates the maturation or degradation of GFP but not of other proteins. Alternatively, an ePTL may affect cell–cell variability in expression of many unrelated genes. This is probably the case for the ura3 mutation as well as dst1 or other mutations impairing transcriptional elongation (Ansel et al, 2008), because all protein-coding genes require proper dynamics of uracil supply and efficient release from elongation pausing. To determine whether the three major ePTLs identified here were specific or pleiotropic, we constructed a reporter that was unrelated to the methionine metabolism. We chose the promoter of the ACT1 gene, which codes for actin, and placed it upstream the GFP coding sequence. We integrated the construct in a BY strain at the HIS3 locus, as we did above for Pmet17-GFP. We then used the introgression strains that are isogenic to BY except for one ePTL. We crossed each of these strains with the Pact1-GFP strain, which generated segregating populations in which linkage could be analyzed. To test the above expectation of pleiotropic cell–cell variability in the context of ura3 or dst1 mutation, we also crossed the Pact1-GFP strain with a ura3 and a dst1 mutant, respectively. In each cross, we tested for a possible linkage between the locus of interest (ePTL, ura3 or dst1) and the CV of Pact1-GFP expression. Spores were generated and genotyped at the locus of interest. They were then cultured in the same condition as above and single-cell GFP expression was quantified by flow cytometry. No association was found between any of the three ePTLs and the CV of Pact1-GFP expression (Figure 3A–C). In contrast, both ura3 and dst1 mutations were associated with increased CV of Pact1-GFP, confirming their expected pleiotropy (Figure 3D and E). None of the loci affected Pact1-GFP mean expression, underlining that differential cell–cell variability is not a by-product of differential mean expression. We conclude that artificial mutations causing impairments in uracil supply or transcriptional elongation generate elevated cell–cell variability with no specificity, whereas natural ePTLs can act specifically on the regulation of the methionine biosynthesis pathway.
We then sought to identify DNA polymorphisms responsible for differences in cell–cell variability. The introgressed region containing ePTL8 was over 50kb in size and contained 25 annotated protein-coding genes. Given this relatively large number, we decided to refine the mapping of ePTL8. We did this by generating a set of haploid strains that were all isogenic to BY except for portions of the region. As shown in Figure 4A, the region is flanked by two genes that can be used as selective markers. THR1 codes for a homoserine kinase essential for threonine biosynthesis (Mannhaupt et al, 1990). The COX6 gene codes for a subunit of cytochrome C oxidase essential for respiration (Gregor and Tsugita, 1982). Thus, both THR1 and COX6 functional genes are required for growth on a synthetic medium lacking threonine and with glycerol as the sole carbon source (Gly, Thr−). Using the strain in which ePTL8 was introgressed, we constructed a diploid strain where the genome was BY/BY homozygous except at the ePTL8 region, which was BY/RM heterozygous and where the RM and BY haplotypes contained a cox6Δ- and a thr1Δ-null mutation, respectively (Figure 4B). This diploid was sporulated, and millions of spores were plated on (Gly, Thr−) selective plates. As expected, only a few colonies were able to grow. We verified that these were not diploid cells but haploids generated from meiotic spores and we mapped the expected recombination events by genotyping eight markers spanning the ePTL8 region (Figure 4C). To see which part of the region showed highest genetic linkage with cell–cell variability, we cultured these strains as above and quantified Pmet17-GFP expression by flow cytometry. Strains differed in both mean and CV of expression. Remarkably, the genotype at position 175005 perfectly distinguished two low-variability strains from the others (Figure 4C). Interestingly, genotype at position 186650 was associated with a difference in mean expression. Thus, generating strains that recombined within the 50kb region allowed us to identify two functional subregions of it. The first one spanned 6kb, between positions 171530 and 177601, and was perfectly associated with Pmet17-GFP cell–cell variability. The second one was larger, from position 177601 to 209170, and was associated with Pmet17-GFP mean expression.
The 6kb region of ePTL8 associated with Pmet17-GFP cell–cell variability contained a single gene, ERC1. Previous studies supported a possible implication of this gene in the regulation of the MET17 promoter. First, erc1 mutants display increased resistance to ethionine, an antagonist of methionine (Shivapurkar et al, 1984; Shiomi et al, 1991). Second, overexpression of ERC1 increases the intracellular concentration of AdoMet (Shiomi et al, 1995), a methyl donor directly derived from methionine and central in the metabolic pathway of sulfur amino acids (Thomas and Surdin-Kerjan, 1997). Finally, the BY and RM alleles of ERC1 were shown to display different transcriptional levels in BY/RM diploid hybrid cells. A slightly preferential expression of the RM allele indicated the presence of functional cis-regulatory polymorphisms in this gene (Ronald et al, 2005). The gene product of ERC1 belongs to the MATE family of transmembrane transporters, which typically possess 12 transmembrane helices (Omote et al, 2006). We aligned the protein sequences of BY and RM and found a frameshift mutation in BY that truncated the last two predicted helices. When aligning protein sequences from other S. cerevisiae and S. bayanus strains, we saw that this mutation was specific to laboratory strains (Figure 4D) and to strain CLIB324, a bakery strain known to be genetically close to laboratory strains (Schacherer et al, 2009). To look for signs of selection, we computed the nonsynonymous over synonymous Ka/Ks ratio of the ERC1 coding sequence, by comparing the RM variant with sequences from S. paradoxus and S. bayanus. This ratio was significantly low (0.05 and 0.025, respectively, P<10−60), suggesting that the protein sequence has been under purifying selection in the wild. Thus, the frameshift mutation of BY reflects a genetic defect acquired in laboratory strains, possibly by genetic drift after the ancestor was brought to the laboratory.
To directly test whether ERC1 sequence polymorphism caused a difference in cell–cell variability of Pmet17-GFP expression, we introduced the BY frameshift mutation in the genome of RM and we removed it from the genome of BY. Such allele-replacement manipulations in S. cerevisiae are traditionally done using integrative plasmids allowing selection (pop-in) and further counterselection (pop-out) (Scherer and Davis, 1979). This requires the cloning of genomic fragments into such plasmids, which is sometimes not convenient when performed in vitro. Some authors developed alternative, cloning-free methods based on oligonucleotides (Storici and Resnick, 2006), but, at least in our hands, these methods were limited by their efficiency of integration in the genome. To bypass the limiting in vitro cloning steps of the plasmid-based strategy, we constructed a vector carrying centromeric and autonomous replication sequences (CEN/ARS) that are flanked by LoxP sites. This vector can be used in its replicative form for in vivo cloning by homologous recombination. The CEN/ARS sequence of the resulting construct can then be excised by the Cre recombinase to obtain an integrative version suitable for pop-in and pop-out (see Materials and methods). Using this strategy, we obtained two independent BY strains carrying an RM-like allele of ERC1, and two independent RM strains carrying a BY-like allele of ERC1 (Supplementary Table S1). Importantly, one of these strains was modified only at the frameshift mutation and two SNPs immediately downstream, allowing to precisely evaluate the implication of this mutation. We analyzed Pmet17-GFP expression in these strains by flow cytometry over a range of methionine concentrations and we computed how much cell–cell variability was gained or lost in response to the allelic replacement. All modified strains displayed a significant change of CV in the expected direction: the RM allele of ERC1 increased cell–cell variability of Pmet17-GFP expression when introduced into BY, to a level similar to the effect attributed above to ePTL8, and the BY allele decreased it when introduced into RM (Figure 4E). Remarkably, the effect was much more pronounced when manipulating the RM strain: introducing a BY allele of ERC1 conferred an even lower CV than the value seen in BY, whereas introducing the RM allele into BY caused a moderate CV increase. This strongly argues for a genetic interaction between ERC1 and additional genes. We saw above that the cumulative effect of ePTL7, ePTL8 and ePTL13 was higher than expected in the BY context, indicating the presence of BY alleles increasing variability (Figure 2G and H). Here we see that ERC1 seems to interact with other loci of the genome, where a BY context does not amplify but attenuates the effect of the mutation. It is therefore likely that several epistatic interactions, sometimes antagonistic, take place between ePTL. Altogether, modifying specifically the ERC1 genotype proved its effect on cell–cell variability of Pmet17-GFP. Given the tight connection between ERC1 and the methionine metabolic pathway, this result explains the observed specific and not pleiotropic effect of ePTL8 (Figure 3B).
The two other major ePTLs were not flanked by genes that can facilitate the selection of recombinant spores. One of them, ePTL7, was a 168-kb region on chromosome VII containing ~80 genes. Knowing that the effect of ePTL7 was not pleiotropic but somewhat specific to the regulation of the MET17 promoter (see above), we searched among these genes for annotations connected to the sulfur and methionine pathway. The MUP1 gene stood out as an interesting candidate because it encodes a methionine permease (Isnard et al, 1996). If the efficiency or dynamics of methionine uptake differ between BY and RM, this may likely generate differences in the level or dynamics of MET17 repression. In addition, MUP1 was previously identified as a cis-eQTL in the BY × RM cross, suggesting a possible differential activity (Smith and Kruglyak, 2008). We therefore examined the possible implication of MUP1 in the modulation of cell–cell variability of Pmet17-GFP expression.
The BY and RM Mup1p proteins are 100% identical in sequence. However, several sequence polymorphisms resided in the promoter region of the gene. Three of these created transcription factor binding sites in RM that were not present on the BY allele (Figure 5A). Sequence alignment of the 750bp promoter region from 29 strains of S. cerevisiae and other species indicated various combinations of the presence/absence of these sites among natural populations (Supplementary Figure S1). Hence, unlike for the ERC1 frameshift mutation described above, laboratory strains did not present a particularly ‘uncommon' MUP1 haplotype. The only noticeable peculiarity was one SNP found only in RM. To test whether these BY/RM polymorphisms conferred different MUP1 promoter activities, we cloned both promoter variants upstream the GFP coding sequence, and we integrated the resulting construct in a BY strain. Flow cytometry quantification indicated a marked difference, with ~2.5 times higher expression when using the RM promoter variant (Figure 5B). This observation explains the cis-eQTL previously reported (Smith and Kruglyak, 2008). To determine whether these cis-regulatory polymorphisms in MUP1 underlay ePTL7, we manipulated the genome of the RM strain and replaced its MUP1 promoter by the BY variant. We obtained four independent strains all carrying the BY version of the promoter. We measured single-cell Pmet17-GFP expression in these strains by flow cytometry at various methionine concentrations and compared them with the unmodified RM strain. All four strains behaved consistently, showing a marked decrease in variability level as compared with RM (Figure 5C). By computing the deviation of the modified strains from a linear model fitted to RM samples, we estimated that the replacement of the MUP1 promoter allele caused a CV reduction of 0.035. This effect is bigger than the gain of variability contributed by ePTL7 in the BY genomic context (0.014, Figure 2H). As for ERC1, this supports the possibility that RM alleles at additional loci may modify the ePTL effect of MUP1. In conclusion, promoter activity tests and the direct manipulation of the MUP1 promoter in its genomic context demonstrated that it is a cis-acting eQTL (RM allele increasing MUP1 transcript level) and a trans-acting ePTL (RM allele increasing Pmet17-GFP expression variability).
The ePTL13 locus did not contain any obvious candidate but we noticed two genes of interest that we tested for a possible effect on Pmet17-GFP expression variability. ATR1 encodes a transmembrane protein implicated in multidrug resistance (Kanazawa et al, 1988). Its mRNA expression is co-activated on boron stress with the expression of genes involved in amino-acid biosynthesis, in a GCN4-dependent manner (Uluisik et al, 2011), and ATR1 was previously identified as a cis-eQTL in the BY × RM cross (Smith and Kruglyak, 2008). The amino-acid sequence of the Atr1p protein is identical between BY and RM. We reasoned that a regulatory polymorphism in the ATR1 promoter could affect cell–cell variability in trans, as in the case of MUP1. We therefore compared the activity of the BY and RM promoter alleles of ATR1 by cloning these promoters in GFP-coding integrative constructs. The BY allele displayed a significantly stronger activity than the RM allele, confirming the earlier cis-eQTL result (Figure 6A). We then performed two functional experiments to test if ATR1 polymorphisms affect Pmet17-GFP expression variability. First, we deleted ATR1 in a BY strain containing the introgressed ePTL13 locus from RM. This alteration did not reduce the elevated cell–cell variability of this strain (Figure 6B). Thus, ePTL13 does not need the presence of ATR1 to increase Pmet17-GFP expression variability. Second, we replaced the endogenous ATR1 promoter of a BY strain by the RM allele. Again, this modification did not modify Pmet17-GFP cell–cell variability (Figure 6C). These two experiments excluded ATR1 as a gene responsible for the effect of ePTL13.
The second gene of interest at ePTL13 was PHO84. This gene encodes a transmembrane transporter of inorganic phosphate (Bun-Ya et al, 1991) that also acts as a sensor to activate the protein kinase A (PKA) pathway (Giots et al, 2003). It was previously identified as a major QTL for the resistance to two polychlorinated aromatic drugs in the BY × RM cross, with a nonsynonymous SNP (L259P) causing this effect (Perlstein et al, 2007). We reasoned that sequence polymorphisms in this gene could modify the dynamics of phosphate transport or the triggering of PKA signaling, with possible consequences on Pmet17-GFP expression variability. To directly test the possible implication of the L259P polymorphism, we quantified Pmet17-GFP variability in a BY strain carrying this SNP. No change was observed in comparison with BY (Figure 6D). To test the possible implication of other polymorphisms (coding or not), we deleted PHO84 in the BY strain containing the introgressed ePTL13 locus from RM. As seen in Figure 6E and F, this mutation had two consequences on Pmet17-GFP regulation: methionine repression was less efficient, and cell–cell variability was reduced (even after accounting for the effect on mean expression). For comparison, we then monitored Pmet17-GFP expression in a fully BY strain carrying the pho84Δ deletion. In this BY context, the consequence of the mutation was different: methionine repression was not impaired and, instead of decreasing, cell–cell variability markedly increased (Figure 6G and H). The fact that BY-pho84Δ and ePTL13-pho84Δ strains differ suggests that polymorphisms in other genes located at ePTL13 modify the effect of pho84Δ deletion on the extent of methionine repression. The fact that pho84Δ increased variability in the BY strain but partially decreased it in the ePTL13 strain suggests that BY and RM PHO84 alleles may have differential impacts on Pmet17-GFP variability. In conclusion, these results support the implication of PHO84 on the modulation of Pmet17-GFP variability and further investigations are needed to completely understand the contribution of this gene and other variants of the locus.
We mapped four natural loci contributing to cell–cell variability in the expression of a Pmet17-GFP fluorescent reporter. Because these loci changed the statistical properties of single-cell gene expression level rather than its mean, we called them ePTLs. Three of these loci were enough to recapitulate the high cell–cell variability seen in the RM parental strain, and they did not affect variability in the expression of an unrelated gene. Allele-replacement experiments demonstrated that natural alleles at two genes, ERC1 and MUP1, both coding for transmembrane transporters, increased cell–cell variability of expression in trans. Deletion of the PHO84 phosphate transporter also affected variability in the expression of the reporter.
All four ePTLs were obtained by introgression mapping. This approach offered several major advantages over traditional schemes. First, it allowed us to decouple two highly correlated traits (mean expression and CV) so that genetic determinants of cell–cell variability per se could be identified. Second, its cost was modest because only three genomes were genotyped instead of a panel of segregants. Finally, in addition to the statistical detection of causative loci, the method produced organisms that were nearly isogenic to one strain except for these loci. These organisms enabled further functional analysis of the locus before the causative sequence polymorphism was identified. Here, the introgressed strains allowed us to test the specificity of ePTL effects, to reduce a candidate region down to a single gene and to perform informative gene-deletion experiments on specific candidate genes. Such introgressed organisms may be invaluable in various studies. They can help identify candidate genes and they can also help scientists decide whether or not the locus is relevant to further discoveries or applications. This is particularly important for traits related to industrial production yields: the effect of an introgressed locus can be tested across small-scale production processes to determine its potential usefulness before investing the effort to identify the causative gene. Introgression mapping is therefore very attractive in the context of organisms offering fast meiotic cycles.
It is remarkable that the two genes identified as ePTLs both coded for a transmembrane transporter. Deletion experiments on PHO84, another transmembrane transporter, also affected cell–cell variability. Transmembrane transporter genes were already pointed at by a previous study because they displayed higher cell–cell variability in expression than other classes of genes. In particular, MUP1 itself was ranked among the ‘noisiest' plasma membrane transporter genes, with 4.7 times higher cell–cell expression variability than average (Zhang et al, 2009). If the MUP1 protein product was the only (or the major) yeast transporter for methionine, then the repressive molecule would be better internalized in cells with high MUP1 expression. Variability in MUP1 expression would therefore generate variability in the methionine-responsive pathway (Figure 7A). However, methionine can be imported into yeast cells by at least seven distinct transporters (Menant et al, 2006). Unless cell–cell variability in the expression of these transporters is coordinated, which is not expected given their different modes of regulation (Menant et al, 2006), expression variabilities of the seven transporters probably compensate one another. Our results show that MUP1 causes cell–cell variability of the methionine pathway by increasing its expression level in all cells of the population (Figure 7B and Supplementary Figure S2). How does this happen? One possibility is that high MUP1 expression confers susceptibility to local variations in methionine concentration. The Mup1p transporter has higher affinity for methionine than all other transporters (Isnard et al, 1996). When abundant at the cell membrane, it probably allows cells to rapidly respond to dynamical changes of extracellular concentrations of methionine. In contrast, if low-affinity transporters predominate, cells may not be as responsive. Although we cultured cells in rather large liquid volumes (typically 4ml) with shaking, the concentration of methionine in the immediate surroundings of each cell was neither constant nor strictly homogeneous. It is therefore possible that the RM promoter variant of MUP1 generates variability by increasing the sensitivity to environmental fluctuations.
Our initial study established cell–cell variability in gene expression as a complex genetic trait but only indirectly, because only one ePTL had been identified and it corresponded to the artificial ura3Δ0 mutation (Ansel et al, 2008). The work presented here fully demonstrates the polygenic architecture of cell–cell variability in gene expression, with the mapping of four additional ePTLs and the identification of two causative natural sequence variants. The fact that genotypes conferring high/low cell–cell variability segregate in natural populations is very important because it makes variability itself an evolvable trait. Alleles at a PTL are potentially subjected to selection, and this may happen in various ways. For example, selection may result from another, deterministic effect of the locus. Alternatively, at least theoretically, it may also result from the benefit of elevated cell–cell variability in certain environmental conditions, especially in unpredictable environments. As mentioned in the Introduction, various studies have shown that phenotypic diversification among clonal cultures can be beneficial upon stressful conditions, which is considered to be a possible bet hedging strategy of adaptation. Experiments and simulations both showed that high cell–cell variability is unfit in fixed environments, and also in dynamic environments that change rapidly because the spontaneous switching rate between phenotypes may then be too slow (Acar et al, 2008; Stomp et al, 2008). In this latter case, a reactive strategy based on efficient sensors of environmental changes is predicted to win (Kussell and Leibler, 2005). However, whether natural genotypes conferring cellular individuality have been selected for in nature because of their benefit in slowly fluctuating environments remains to be demonstrated.
Here we show that several laboratory yeast strains acquired an erc1 frameshift mutation that reduces cell–cell variability of MET17 expression. Laboratory strains are maintained without selection pressure and across extreme population bottlenecks (propagation of single-cell colonies). This breeding habit results in ‘wild-type' reference laboratory strains having accumulated slightly deleterious mutations that would likely be counterselected in nature (Yvert et al, 2003; Warringer et al, 2011). The erc1 frameshift mutation in BY likely results from such a genetic drift, as it suppresses two predicted C-terminal helices that are conserved across wild species. Accordingly, the observed low Ka/Ks ratio suggests negative selection on the protein sequence in the wild. The ERC1 example therefore suggests that a PTL can originate from a loss of selective pressure on a protein sequence. Interestingly, the effect of this mutation is to reduce cell–cell variability in the methionine synthesis pathway as compared with the wild allele. This does not imply that ERC1 is under selection for maintaining elevated variability. What this suggests is the following: let ΔFvar be the fitness cost of maintaining cell–cell variability in MET17 expression, and let ΔFerc1 be the fitness cost of altering the C-terminal part of the Erc1p protein, then ΔFvar<ΔFerc1. In other words, if elevated variability in MET17 expression impaired fitness dramatically (very high ΔFvar), then cells would be more fit with a modified Erc1p sequence and altered ERC1 alleles should be found in the wild, which is not the case. Thus, some level of cell–cell variability in MET17 expression is maintained by ERC1 in the wild, either because it is beneficial (which remains to be determined) or because suppressing it would be too costly.
It is more difficult to make evolutionary considerations on MUP1. The sequence polymorphism of interest is noncoding, and various combinations of the BY/RM SNPs can be found in wild alleles. Identifying which SNP or combination of SNPs affect MET17 expression variability would require a systematic and dedicated set of additional experiments. It is nonetheless worth noting that its protein sequence is highly conserved and under apparent negative selection (Ka/Ks=0.035 between S. cerevisiae and S. paradoxus). Thus, the previously suggested positive selection for expression variability acting on this gene (Zhang et al, 2009) evolved within the constraint of maintaining the protein sequence unchanged.
The fact that the pho84Δ mutation had different effects when introduced into the BY or RM haplotype of the locus is interesting. It suggests that other polymorphisms of the locus are in genetic interaction with PHO84 to modulate Pmet17-GFP single-cell expression distribution. It can also be partly explained if a differential activity of BY and RM alleles of PHO84 affects Pmet17-GFP variability. In this case, deletion of the gene causes the removal of different molecular activities when done in the BY or in the RM context of the locus. We ruled out the implication of the L259P polymorphism, but different activities could result from another nonsynonymous SNP (D55N) or from noncoding ones. Identifying the precise genetic determinants of this effect would enable studying the mechanism involved and, in particular, whether it relates to phosphate transport, PKA activation or both.
Three of the four ePTLs mapped modified the expression variability of Pmet17-GFP but not of Pact1-GFP. This specificity is consistent with the previous observation of coordinated levels of cell–cell variability among functionally related genes (Stewart-Ornstein et al, 2012). Although additional PTL examples are needed before drawing a general conclusion, our results suggest that natural PTLs affect cell–cell variability on specific pathways rather than pleiotropically. This modularity is likely advantageous for adaptation: some genotypes may increase cell–cell variability in a specific stress response or nutritional sensing without perturbing other physiological regulations. This way, various traits may be diversified independently in a population of cells, and if variability in one trait is beneficial for adaptation, it can be fixed while maintaining homogeneity of other traits.
Perhaps the most interesting evolutionary aspect of finding PTL sequence variants in environmental sensor genes is that it connects two previously opposed strategies of adaptation: anticipation by phenotypic diversification (probabilistic bet hedging) versus high reactivity to environmental changes (deterministic response) (Kussell and Leibler, 2005). The MUP1 and ERC1 sequence variants identified here act on both aspects. They improve the responsivity of cells to environmental changes in a deterministic way, and they increase cell–cell variability of MET17 expression in a probabilistic way. Thus, mutations in environmental sensor genes may provide natural populations with a way to tune both adaptive strategies simultaneously.
Yeast strains and DNA oligonucleotides used in this study are listed in Supplementary Tables S2 and S3, respectively.
Yeast cultures (synthetic medium, 2% glucose, 30°C) and flow cytometry acquisitions were performed as previously described (Ansel et al, 2008). An overnight culture was diluted to OD600=0.1 in medium supplemented with 1mM methionine (repressive condition) and grown for 3h. Cells were then resuspended in medium containing 50μM methionine, or divided in aliquots that were resuspended in a range of methionine concentrations (0, 5, 20, 50, 100, 150 and 200μM). Cells were then grown for 2h and analyzed on a FACSCalibur cytometer (BD Biosciences). Analysis of flow cytometry data was done using R (www.r-project.org) and the flowCore package of Bioconductor (www.bioconductor.org). GFP fluorescence (FL1 values) was corrected for cell size and granulometry by conditioning FL1 on Log(FSC) and Log(SSC), as previously described (Ansel et al, 2008). Cell–cell variability was calculated here as the CV (s.d. divided by mean) of the transformed intensities.
Introgression mapping was initiated in our previous study, where partial genotyping of two strains (GY159 and GY174) that retained high CV values but carried only ~6.25% of the RM11-1a genome revealed the implication of ura3 as a QTL of cell–cell variability in the expression of Pmet17-GFP (Ansel et al, 2008). Here we pursued the introgression by backcrossing these strains further with BY-derived strains. At every meiosis step, a spore displaying high CV and similar mean, as compared with BY, was chosen among 30–40 spores. Three backcrosses of GY174 led to GY768 (X7), and three backcrosses of GY159 led to GY769 (Z7). A third introgression lineage was initiated from GY601, an RM11-1a-derived strain harboring wild-type URA3. GY601 was backcrossed 7 times with BY derivatives, leading to strain GY793 (W7). This way, all three strains GY768, GY769 and GY793 had a wild-type URA3 gene, had ~1–2% of their genome originating from RM11-1a independently and displayed increased CV but unaffected mean expression as compared with BY. Genomic DNA of these three strains and of RM11-1a was extracted as previously described (Ansel et al, 2008) and subjected to whole-genome resequencing using paired-end sequencing on Illumina Genome Analyzer IIx. The sequencing reads from 4 samples (RM11-1a, W7, X7 and Z7) were aligned to S. cerevisiae S288c genome (http://www.yeastgenome.org) using novoalign V2.06.09 (http://www.novocraft.com) with parameters -rRandom -Q 75. SNPs were inferred by comparing the frequencies of each nucleotide at certain positions to the frequencies obtained from a previous resequencing of a BY strain. We obtained a list of 42794 RM11 SNPs, which identified 11 regions that were ePTL candidates for the control of cell–cell variability of Pmet17-GFP expression (Table I). To validate or reject these regions as ePTLs, we crossed one more time the introgressed strains with a BY derivative (either GY51 or GY172), isolated random spores, analyzed them by flow cytometry and genotyped them at the locus of interest using restriction fragment length polymorphism (RFLP) PCR (Supplementary Table S3). For every cross, we used a linear regression to condition CV on mean based on the data of all spores, and we used the residuals as quantitative trait values of the spores. We then tested for linkage between this trait and genotype at the locus by splitting the spores in two groups based on their genotype, and applying the Wilcoxon Mann–Whitney test on the null hypothesis of no trait difference between the two groups. Finally, to quantify the effect of each validated PTL, we constructed strains GY915, GY919, GY926 and GY927 that had retained the PTL locus but no other loci from RM11-1a, as determined by RFLP markers (Supplementary Table S3). We quantified by flow cytometry the expression of Pmet17-GFP in replicated cultures of these strains across a range of methionine concentrations. During all experiments, the BY-derived strain GY172 or GY51 was also cultured and acquired in parallel for quantitative comparison.
To test the pleiotropy of ePTLs, a synthetic Pact1-GFP construct flanked with BamHI sites was purchased from GeneCust Europe (Dudelange, Luxembourg) and cloned into the BamHI site of the pHO-poly-KanMX4-HO plasmid (Voth et al, 2001). A NotI fragment of this plasmid was transformed into strain BY4713 (Brachmann et al, 1998) to generate strain GY975 where the Pact1-GFP reporter was integrated at the HO locus. This strain was then crossed with strain GY930 (derived from GY919), random spores were isolated, analyzed by flow cytometry in the exact same conditions as above and genotyped at ePTL8 using RFLP PCR (Supplementary Table S3). Similarly, strain GY935 was crossed with GY975 and spores were analyzed by flow cytometry and genotyped at ePTL7 using RFLP PCR (Supplementary Table S3); strain GY512 was crossed with GY975, spores were analyzed by flow cytometry and genotyped at DST1 by PCR; and strain BY4719 was crossed with GY975, spores were analyzed by flow cytometry and their URA3 locus was typed on −URA plates. The pleiotropy of ePTL13 was tested using strain GY1156, which harbors the same synthetic Pact1-GFP construct integrated at the HO locus except for the KanMX4 marker, which was replaced by TRP1. This strain was crossed with GY915 and random spores were analyzed by flow cytometry and genotyped at the ePTL using RFLP markers (Supplementary Table S3).
The diploid strain GY939 from which recombinant spores of the chrVIII interval were obtained was constructed as follows. Strain GY919 was crossed with BY4716 to obtain strain GY930, bearing the introgressed locus but lacking the Pmet17-GFP-NatMX4 construct. To inactivate the COX6 gene by homologous recombination, the cox6Δ::KanMX4 locus from a strain bought from EUROSCARF was amplified with primers 1H29 and 1H30 and transformed into GY930, leading to strain GY931. Independently, a EUROSCARF strain thr1Δ::KanMX4 derived from the BY(S288c) background was crossed with GY172 to obtain GY929, harboring both the thr1 mutation and the Pmet17-GFP-NatMX4 reporter cassette. GY929 was mated with GY931 to obtain GY939. This diploid was sporulated on potassium acetate plates, and random spores were plated on synthetic medium lacking threonine and supplemented with 3% glycerol as the sole carbon source. Spores were genotyped at markers within the introgressed locus in order to map recombination events.
Protein sequences of ERC1 were downloaded from SGD (http://www.yeastgenome.org/), aligned using ClustalW with default parameters, and the alignment was manually corrected. The Ka/Ks ratio was computed by first aligning the coding sequence of RM11-1a (S. cerevisiae) with sequence MIT_Spar_C37_10276 (S. paradoxus) using ClustalW, and then applying the average method over multiple models implemented in the KaKs_Calculator version 1.2 software (Zhang et al, 2006). The same was done to compare the RM11-1a sequence with sequence MIT_Sbay_c47_10440 (S. bayanus). The promoter sequences of MUP1 were downloaded from SGD, aligned with ClustalW and the alignment was manually corrected.
To perform allele replacements, we first constructed a centromeric plasmid, pALREP, harboring the KlURA3 selectable marker, and where the CEN-ARS replicative sequence was flanked by LoxP sites. This way, the plasmid can be used in a replicative version for high-efficiency cloning using homologous recombination in yeast, and then, after Cre-mediated excision of CEN-ARS, as an integrative version for targeted mutagenesis. To construct this plasmid, we first removed one LoxP site from plasmid pUG-KlURA3 (Delneri et al, 2000) by digestion with SacII and religation. Resequencing of the resulting plasmid indicated that the SacII site was destroyed by the process. We then amplified the LoxP-CEN-ARS-LoxP segment from plasmid pDS163 (Sinclair and Guarente, 1997) by PCR with primers containing StuI and NheI sites and the amplicon was cloned into the PvuII and XbaI sites of the modified pUG-KlURA3 plasmid.
The ERC1 locus was amplified from RM11-1a genomic DNA by Herculase polymerase (Agilent Technologies Inc.) using primers 1I12 and 1I13. This amplicon was cotransformed in a yeast ura3Δ0 strain with pALREP linearized at HpaI for cloning by homologous recombination. The resulting plasmid was verified by restriction mapping and transferred in bacteria carrying the 705-Cre expression system (Gene Bridges GmbH), where expression of the Cre recombinase was transiently induced. Plasmid molecules were extracted and retransformed in E. coli to select a plasmid (pGY251) where the CEN-ARS sequence had been excised. Strain GY246 (Ansel et al, 2008) was transformed with pGY251 linearized at NcoI and two URA+ transformants (GY1008 and GY1009) were chosen on the basis of proper integration as determined by AvrII RFLP PCR amplified with 1H89 and 1H90 primers. GY1008 and GY1009 were transferred to 5FoA plates to select for loss of KlURA3, leading to strains GY1023 and GY1024, respectively. Final genotypes were verified by AvrII RFLP PCR amplified with 1H89 and 1H90.
Similarly, the ERC1 locus was amplified from BY genomic DNA by Herculase polymerase (Agilent Technologies Inc.) using primers 1I12 and 1I13, cloned in pALREP, and the CEN-ARS sequence of the resulting plasmid was excised as above to generate plasmid pGY250. This plasmid was linearized at NcoI and integrated into strain GY53 by selection on −URA plates. Transformants were verified by AvrII RFLP using primers 1H89 and 1H90 and one strain harboring the desired BY allele (GY1010) was replicated on 5FoA plates for loss of KlURA3. Two strains resulting from independent recombination events, GY1019 and GY1020, were selected based on proper genotype at the AvrII RFLP.
A similar approach was applied to replace the MUP1 promoter. A MUP1 fragment was amplified from BY genomic DNA using Herculase (Agilent Technologies Inc.) with primers 1I32 and 1I29 and cloned by homologous recombination in pALREP linearized at HpaI. The CEN/ARS sequence of the resulting plasmid was excised by transient expression of the Cre recombinase in E. coli as above to produce plasmid pGY256. Strain GY53 (Ansel et al, 2008) was transformed with pGY256 linearized at EcoRI. URA+ transformants were genotyped by PCR and sequencing to verify proper integration. One of them was then plated on 5FoA plates to select for loss of KlURA3. Four strains resulting from independent pop-out events (GY1205, 1206, 1207 and 1208) displayed the BY genotype at all SNP positions of the MUP1 promoter, as determined by high-resolution melting PCR with primers 1I80 and 1I81, and sequencing of PCR product obtained with primers 1G84 and 1G85.
The ATR1 promoter was replaced similarly by cloning into pALREP, a PCR fragment amplified from RM genomic DNA with primers 1J10 and 1J11, and removing the CEN/ARS sequence by Cre/lox excision. The resulting plasmid pGY303 was linearized at BsaBI and integrated into strain GY246. URA+ transformants were genotyped by PCR (primers 1J12, 1J13) and one of them (GY1329) was replica-plated on 5FoA plates to select for loss of KlURA3, which led to strain GY1330.
To obtain a convenient plasmid for GFP reporter activity, we modified pGY8 (Ansel et al, 2008) by adding in it the lox-CEN/ARS-lox sequence of pALREP and changing the MET17 promoter by the PGK promoter directly upstream the GFP coding sequence. This plasmid, pGY252, was then modified by homologous recombination to replace the PGK promoter by the MUP1 promoter amplified from RM genomic DNA using Herculase DNA polymerase with primers 1I35 and 1I36. The resulting plasmid (pGY257) was then treated by the 705-Cre system as above to excise the CEN/ARS region, generating an integrative plasmid (pGY260) that was linearized by NheI within the HIS3 cassette and integrated in strain BY4716. This produced three independent transformants, GY1002, GY1003 and GY1004. Similarly, the MUP1 promoter of BY was amplified and cloned into pGY252, the resulting plasmid was modified to become integrative (plasmid pGY261) and transformed into BY4716 to produce three independent transformants, GY1005, GY1006 and GY1007.
Similarly, the ATR1 promoter was amplified from BY and RM genomic DNA using primers 1I98 and 1I99 and cloned into pGY252 by homologous recombination to produce plasmids pGY296 and pGY297, respectively. Their CEN/ARS sequence was removed by Cre/Lox excision, and the resulting plasmids were linearized at NheI and integrated into strain BY4716 to produce strains GY1325 and GY1326 (independent transformants) as well as GY1327 and GY1328 (independent transformants).
The atr1Δ::KanMX4 allele was amplified from EUROSCARF strain Y16516 using primers 1J06 and 1J07 and transformed into strain GY1284 to produce strain GY1302, which was then crossed with GY172 to produce GY1309. Similarly, the pho84Δ::KanMX4 allele was amplified from EUROSCARF strain Y16524 using primers 1J08 and 1J09 and transformed into strain GY1284 to produce GY1303, which was then crossed with GY172 to produce GY1310.
We are grateful to Martine Collart, Magali Richard and Valérie Robert for critical reading of the manuscript, Soizic Riche for technical help, Leonid Kruglyak for the PHO84-L259P strain, the Pôle Scientifique de Modélisation Numérique (Lyon, France) for computer resource, Sandrine Mouradian and SFR Biosciences Gerland-Lyon Sud (UMS3444/US8) for access to flow cytometers and thermal cyclers, Franck Vittoz for the design and construction of prototype labware equipments, developers of R, Bioconductor, Lyx and Ubuntu for their software and three anonymous reviewers for their comments. This work was supported by Grant ANR-07-BLAN-0070 from the Agence Nationale de la Recherche France (to GY), by the European Research Council under the European Union's Seventh Framework Programme FP7/2007–2013 Grant Agreement no. 281359 (to GY) and by the National Institutes of Health (to LMS).
Author contributions: SF and AL: performed experiments and analyzed the data; HB-D, EM and AB: performed experiments; WW: analyzed genome re-sequencing data; LMS: contributed reagents; GY: conceived and designed the study, analyzed the data, wrote analysis codes, interpreted results and wrote the paper.
The authors declare that they have no conflict of interest.